Other (13)
- ANALYTE_TYPE - Analyte Type (phv00265844.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00265843.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00265838.v1.p1)
- Funding_Source - Project funding source (phv00395266.v1.p1)
- IS_TUMOR - Tumor status (phv00265845.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00265842.v1.p1)
- SAMPLE_ID - Sample ID (phv00265840.v1.p1)
- SEQUENCING_CENTER - Sequencing Center where sample was sequenced (phv00265992.v1.p1)
- Study_Name - TOPMed-assigned short study name (1:1 with TOPMed phs number) (phv00395269.v1.p1)
- SUBJECT_ID - Subject ID (phv00265837.v1.p1)
- SUBJECT_ID - Subject ID (phv00265839.v1.p1)
- TOPMed_Phase - TOPMed Phase (phv00395267.v1.p1)
- TOPMed_Project - TOPMed Project that funded sequencing (phv00395268.v1.p1)